SOLIGENIX INC (SNGX) Fundamental Analysis & Valuation

NASDAQ:SNGX • US8342236044

Current stock price

1.15 USD
+0.03 (+2.68%)
At close:
1.1678 USD
+0.02 (+1.55%)
Pre-Market:

This SNGX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SNGX Profitability Analysis

1.1 Basic Checks

  • In the past year SNGX has reported negative net income.
  • SNGX had a negative operating cash flow in the past year.
  • SNGX had negative earnings in each of the past 5 years.
  • In the past 5 years SNGX always reported negative operating cash flow.
SNGX Yearly Net Income VS EBIT VS OCF VS FCFSNGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of SNGX (-123.07%) is worse than 80.43% of its industry peers.
  • SNGX has a worse Return On Equity (-214.77%) than 71.32% of its industry peers.
Industry RankSector Rank
ROA -123.07%
ROE -214.77%
ROIC N/A
ROA(3y)-91.62%
ROA(5y)-83.64%
ROE(3y)-217.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNGX Yearly ROA, ROE, ROICSNGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SNGX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SNGX Yearly Profit, Operating, Gross MarginsSNGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SNGX Health Analysis

2.1 Basic Checks

  • SNGX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SNGX has more shares outstanding
  • The number of shares outstanding for SNGX has been increased compared to 5 years ago.
  • SNGX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SNGX Yearly Shares OutstandingSNGX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
SNGX Yearly Total Debt VS Total AssetsSNGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of -39.01, we must say that SNGX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -39.01, SNGX is doing worse than 90.50% of the companies in the same industry.
  • SNGX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -39.01
ROIC/WACCN/A
WACC9.55%
SNGX Yearly LT Debt VS Equity VS FCFSNGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

2.3 Liquidity

  • A Current Ratio of 2.39 indicates that SNGX has no problem at all paying its short term obligations.
  • SNGX's Current ratio of 2.39 is on the low side compared to the rest of the industry. SNGX is outperformed by 72.48% of its industry peers.
  • SNGX has a Quick Ratio of 2.39. This indicates that SNGX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of SNGX (2.39) is worse than 68.99% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 2.39
SNGX Yearly Current Assets VS Current LiabilitesSNGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SNGX Growth Analysis

3.1 Past

  • SNGX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.16%, which is quite impressive.
  • The Revenue for SNGX has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)55.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.44%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, SNGX will show a very strong growth in Earnings Per Share. The EPS will grow by 31.11% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y69.66%
EPS Next 2Y31.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SNGX Yearly Revenue VS EstimatesSNGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 2M 4M 6M 8M 10M
SNGX Yearly EPS VS EstimatesSNGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

1

4. SNGX Valuation Analysis

4.1 Price/Earnings Ratio

  • SNGX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SNGX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNGX Price Earnings VS Forward Price EarningsSNGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNGX Per share dataSNGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

  • SNGX's earnings are expected to grow with 31.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.11%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SNGX Dividend Analysis

5.1 Amount

  • No dividends for SNGX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SNGX Fundamentals: All Metrics, Ratios and Statistics

SOLIGENIX INC

NASDAQ:SNGX (4/13/2026, 8:00:02 PM)

Premarket: 1.1678 +0.02 (+1.55%)

1.15

+0.03 (+2.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-31
Earnings (Next)05-07
Inst Owners4.35%
Inst Owner Change0%
Ins Owners0.15%
Ins Owner Change0%
Market Cap11.86M
Revenue(TTM)N/A
Net Income(TTM)-11.37M
Analysts82.86
Price Target17.85 (1452.17%)
Short Float %6.71%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)24.26%
Min EPS beat(2)-2.46%
Max EPS beat(2)50.98%
EPS beat(4)2
Avg EPS beat(4)1.51%
Min EPS beat(4)-55.11%
Max EPS beat(4)50.98%
EPS beat(8)5
Avg EPS beat(8)6.62%
EPS beat(12)8
Avg EPS beat(12)17.58%
EPS beat(16)10
Avg EPS beat(16)-5.55%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.24
P/tB 2.24
EV/EBITDA N/A
EPS(TTM)-2.74
EYN/A
EPS(NY)-0.83
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS0
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -123.07%
ROE -214.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-91.62%
ROA(5y)-83.64%
ROE(3y)-217.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 184.38%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 2.39
Altman-Z -39.01
F-Score3
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.44%
EPS Next Y69.66%
EPS Next 2Y31.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.17%
OCF growth 3YN/A
OCF growth 5YN/A

SOLIGENIX INC / SNGX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SOLIGENIX INC?

ChartMill assigns a fundamental rating of 2 / 10 to SNGX.


What is the valuation status of SOLIGENIX INC (SNGX) stock?

ChartMill assigns a valuation rating of 1 / 10 to SOLIGENIX INC (SNGX). This can be considered as Overvalued.


How profitable is SOLIGENIX INC (SNGX) stock?

SOLIGENIX INC (SNGX) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for SNGX stock?

The Earnings per Share (EPS) of SOLIGENIX INC (SNGX) is expected to grow by 69.66% in the next year.